Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168)

计划入组 1,131 人 · 首次发布于 2020 年 6 月 2 日

Accelerating Motor Recovery in Glioma Patients Using Postoperative nrTMS

计划入组 43 人 · 首次发布于 2025 年 12 月 16 日

TRPMS to Improve Mobility and Depression in Multiple Sclerosis

首次发布于 2020 年 10 月 8 日

gene therapy (ICRT/RPMS)

Tolebrutinib Receives FDA Breakthrough Therapy Designation for Non-Relapsing Secondary Progressive Multiple Sclerosis

Sanofi's Tolebrutinib Shows Promise in Non-Relapsing Secondary Progressive MS

Tolebrutinib Shows Promise in Slowing Disability Progression in Non-Relapsing Secondary Progressive MS